A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice

Inclusion Criteria

• •1. Must have understood and voluntarily signed the Informed Consent Form (ICF).
• •2. Age ≥ 18 years at the time of signing the ICF.
• •3. Diagnosed with plaque psoriasis.
• •4. Initiated treatment with apremilast 6 months (+/- 1 month) previously (patients may or may not have completed 6 months of apremilast treatment)